This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
miLab Platform Products
Improve diagnostic workflows
Improve diagnostic workflows
and accessibility at once
Beyond Diagnostics
We provide products and services that impact
We provide products and services that impact
one billion people's life in the world.
Noul focuses on the most challenging healthcare issues the world has yet to resolve.
We deliver innovative diagnostic solutions in blood and tissue diagnostics dramatically improve medical access and
conquer cancer.
-
Our Story in Numbers
- NVIDIA GTC selected AI Startups
- Top 0
- Cumulative investment (USD)
- 0million
- Annual sales growth (as of 2023)
- 0%
We continues to grow, moving toward the next stage.
-
- Patent registrations and applications
- 0cases, 0cases
- Cumulative orders for National R&D project (USD)
- 0million
- Researcher in company
- 0%
We creates innovation based on R&D and technology patents.
-
- Countries using miLab™
- 0countries
- Cumulative diagnosis using miLab™
- 0diagnoses
- Partner organizations
- 0+
miLab™ Solution leads the global blood and cancer diagnosis.
-
- Digitalize entire process (stain, scan, AI analyze)
- All inOne
- Time required for diagnosis (more than 2x improvement)
- Avg0mins
- Accuracy of test results (Based on miLab™ MAL)
-
Sensitivity0% ,
Specificity0%
miLab™ Solution has dramatically improved the diagnostic process.
Noul Highlights
Find our latest news
View More-
Noul, a top On-Device AI healthcare company, joins CancerX, a cancer-fighting project led by the U.S. White House
As part of the Cancer Moonshot initiative announced at the White House, noul is delighted to announce its groundbreaking participation as a leading On-Device AI healthcare company in the private-public partnership, CancerX. Congratulations on noul’s efforts to take a step closer to global cancer conquest! CancerX… Read More
News | 2024.02.26
-
[Press Release] On-Device AI Healthcare Company Noul Becomes an Official Member of Swiss Malaria GroupOn-Device AI Healthcare Company Noul
Obtain a membership in recognition of innovation in malaria diagnostic solution Strengthen global leadership in malaria diagnosis based on European subsidiary (Yongin, Korea) February 9, 2023 – Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that its European subsidiary (noul GmbH) has become an official member of… Read More
News | 2024.02.09
-
Noul @ MEDICA 2023
Noul participates MEDICA 2023 from Nov 13 to 16. Noul team will showcase AI-driven blood and cancer diagnostic platform, miLab™ on the site. At our booth, you can also find our new product which is automatically staining and analyzing cervical cells. COME AND MEET US AT MEDICA 2023! Please… Read More
Event | 2023.11.10
-
[Press Release] AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana
Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 Noul’s ‘miLab™’ showed significantly higher sensitivity than that of microscopy in health centers (Yongin, Korea) October 23, 2023 – Noul Co., Ltd., (376930.KR), an Artificial Intelligence (AI) based blood… Read More
News | 2023.10.23
-
Noul @ ASCP 2023
Introducing Noul’s new miLab product for Cervix at the upcoming ASCP exhibition.Noul team will showcase a new AI-based cervical cell analyzer, the product automatically staining and analyzing cervical cells. Learn about the latest of our products and discuss more at ASCP. ✅ Exhibition Info. – Date: October 18-20– Location: Long Beach… Read More
Event | 2023.10.12
-
[Press Release] AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product
Unveil ‘miLab™ Cartridge CER’, a cervical cell analysis product followed by malaria diagnostic and blood cell morphology analysis products Overcome the limitations of HPV testing by identifying the detailed stages of cervical pre-cancer/cancer with cervical cytology as a screening method (Yongin, Korea) October 9, 2023 – Noul Co., Ltd.,… Read More
News | 2023.10.09
-
Career
Join our team, committed to
making a positive impact - View More
-
Sustainability at Noul
Sustainability is
at the core of our business philosophy. - Sustainability
